NEW YORK (GenomeWeb News) — Illumina has withdrawn its offer to acquire Complete Genomics, according to a filing submitted to the US Securities and Exchange today.

According to the filing, Illumina has also notified the Federal Trade Commission that it is withdrawing a Hart-Scott-Rodino merger prenotification filing related to the proposed acquisition.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.